Ticagrelor
Ticagrelor prevents platelets from forming arterial clots and is used within selected coronary treatment plans. Duration and accompanying medicines are determined by the treating cardiac team.
Key points
- Ticagrelor is commonly used with another antiplatelet medicine, but the exact combination must follow the prescribed plan.
- Stopping treatment independently can increase the risk of a heart attack or a clot in a coronary stent.
- Bleeding and breathlessness are important adverse effects; severe or unexplained symptoms need assessment.
Listings are for comparison only; suitability and supply depend on the cardiac indication, prescription, interaction and bleeding checks, and pharmacy review.
What ticagrelor is used for
Ticagrelor may be used after acute coronary syndrome or selected coronary procedures to reduce future clot-related events. Treatment length is individual to the cardiac plan.
How it works
Ticagrelor reversibly blocks platelet P2Y12 receptors, reducing platelet activation. Platelet function does not return immediately when a dose is missed or treatment is stopped.
Important safety checks
Review active or previous bleeding, stroke history, liver disease, slow heart rhythm, breathing symptoms, planned surgery and all anticoagulants, antiplatelets, NSAIDs and interacting medicines. Tell the procedural team about ticagrelor before surgery or dental treatment.
When to seek urgent care
Seek urgent help for uncontrolled bleeding, vomiting or coughing blood, black stools, a sudden severe headache, fainting, signs of stroke, chest pain or severe breathlessness.